Shernan Holtan

19PUBLICATIONS
112CO-AUTHORS
Gene and molecular therapyHaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Rehabilitation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 03, 2026
TA-TMA and GVHD are distinct consequences of endothelial injury: A MIDAS consortium study.

|Apr 15, 2026
Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age.

|Mar 20, 2026
Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple Myeloma.

Ehsan Malek, Brian Betts, Megan Herr

|Feb 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.

Jakob Wirbel, Wael Saber, Michael J Martens

|Jan 27, 2026
Targeting Aurora kinase A to prevent GVHD and relapse after myeloablative allogeneic hematopoietic cell transplantation.

Shernan G Holtan, Punita Grover, Kelly Walton

|Sep 18, 2025
ICANS and mortality after CAR-T therapy for NHL patients can be predicted using physical function measures of falls, balance and strength deficits, and use of an assistive device.

Nisha M Nair, Theresa E Hahn, Hillary Jacobson

Pageof 4

Frequent Collaborators

10 joint publications

Daniel Weisdorf

6 joint publications

Alexander Khoruts

6 joint publications

Christopher Staley

6 joint publications

Armin Rashidi